ARTICLE | Company News
PrimeraDx, National Cancer Institute pharmacogenetics news
October 1, 2012 7:00 AM UTC
PrimeraDx received a grant from the institute's Innovative Molecular Analysis Technologies program to develop an assay to rapidly detect diffuse large B cell lymphoma subgroups. PrimeraDx will use its...